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Objectives: To assess sleep quality and timing in children with Angelman syndrome (AS) 
with sleep problems using questionnaires and actigraphy and contrast sleep parameters 
to those of typically developing (TD) children matched for age and sex.
Methods: Week-long actigraphy assessments were undertaken with children with AS 
(n = 20) with parent-reported sleep difficulties and compared with age and sex matched 
TD controls. The presence of severe sleep problems was assessed using the modified 
Simonds and Parraga sleep questionnaire. Sleep hygiene was measured using the Family 
Inventory of Sleep Habits.
Results: Actigraphy and parent-completed sleep diary data indicated that children with 
AS had significantly earlier bedtimes (p = .003, Cohen d = .47) and poorer sleep efficiency 
(78%, p = .04, d = .33) than TD children (84%). No significant differences in total sleep 
time, sleep onset latency or wake after sleep onset were found between the two groups. 
The expected relationship between later bedtimes and increasing age found for the TD 
group (p < .001, β.78) was not evidenced for the AS group (p = .09, β.39). Considerable 
inter-individual and night to night variation in actigraphy assessed total sleep time and 
wake after sleep onset was found for children with AS compared to TD children. Parent 
report indicated that a greater proportion of children with AS had severe night waking 
problems compared to TD children (81 versus 5%). No significant differences in sleep 
hygiene and excessive daytime sleepiness were found between the two groups (p > .05).
Conclusions: This study reports the largest objective dataset of sleep quality parameters 
in children with AS. Sleep quality in this group was characterised by poor efficiency and 
significant intra- and inter-individual variability that warrants further investigation. This 
variability should inform assessment and intervention for sleep in children with AS, as 
averages of total sleep, even across a 7 day period may not capture the difficulties with 
night waking highlighted by parental questionnaire report.
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inTRODUCTiOn
Angelman syndrome (AS) is caused by lack of expression of the 
UBE3A gene on the maternal 15q11–13 chromosome, arising 
from various genetic mechanisms (1). These mechanisms include 
a 5–7 Mb De Novo interstitial deletion of the maternal 15q11.2–
Q13 region for approximately 75% of individuals, Paternal 
Uniparental Disomy (UPD) (1–2%), an Imprinting Defect 
(1–3%), and mutation in the UBE3A gene (10%) (2).
Several physical and behavioural features are consistently 
associated with AS, which include severe developmental delay, 
ataxic gait, frequent smiling/laughing, repetitive arm movements 
and limited or absent speech (3). Other characteristics present 
in over 80% of individuals include microcephaly, seizures, and 
abnormal EEG (3). Sleep disturbances, including insomnia and 
general sleep disorders or difficulties, are widely reported in AS (4). 
A systematic review of studies investigating sleep disturbances in 
children with genetic syndromes reports prevalence rates of sleep 
disturbances in children with AS of between 48% and 70% (5). 
Sleep disturbance in AS may occur downstream from impaired 
UBE3A expression resulting in the dysfunction of GABA receptors 
(6, 7). A number of studies have suggested that individuals with AS 
do experience circadian rhythm disorders (8) evidenced by a shift 
in melatonin offset timings relative to TD children and children 
with epilepsy (9). However, whether individuals with AS secrete 
a smaller volume of endogenous melatonin than peers is unclear 
(8, 9). More specifically, Takaesu et al. (8) identified 53% of their 
sample of 15 individuals with AS to have a circadian rhythm 
disorder, including an irregular sleep–wake cycle disorder (26.7%), 
non-24-h sleep–wake cycle (13.3%), and delayed sleep phase 
disorder (13.3%). Impaired circadian rhythm implicating the 
activity of E6-AP encoded by the affected UBE3A gene specific to 
AS has been hypothesized (10). Thus, in the investigation of sleep 
disturbance in AS, there is a need to characterize the specific sleep 
disturbances experienced by children with AS using validated 
questionnaires and objective measures and evaluate sleep phase, 
given possible circadian rhythm disorders.
Specific problems relating to sleep reported in children with 
AS include increased sleep onset latency, bedtime resistance, 
anxiety, rhythmic movements whilst falling asleep, nocturnal 
wakings, sleep disordered breathing and daytime sleepiness (6). 
Prevalence rates for night waking range from 60 to 100%, with a 
decrease in waking observed with increasing age (11). Variability 
in reported prevalence rates may be due to different definitions of 
night waking used across studies. When quantifying the severity 
of night waking as three or more times a week and lasting over 
several minutes, the prevalence was 46% of children with AS 
(mean age 8.64 years) (12).
Little is known about the impact of sleep disturbance on 
children with AS. Daytime sleepiness according to single items on 
questionnaires is reported for only between 8 and 24% of children 
(6, 13–15) and represents a small effect size (.10) in a meta-analysis 
(16). This raises questions as to whether children with AS have a 
reduced need for sleep and whether shortened total sleep time 
negatively impacts upon children’s daytime functioning. Whilst the 
behavioural impact of shortened sleep duration has not been studied 
in children with AS, children with severe intellectual disabilities with 
sleep problems have a greater severity of challenging behaviour (17). 
The reduced total sleep time may be due to increased sleep onset 
latency, reported for between 32% and 91% of individuals (6, 13, 18), 
in combination with reduced sleep efficiency due to night wakings 
(7, 19). The range of definitions for night waking and the inclusion 
of young adults in some of these studies limit the conclusions that 
can be drawn from these data. Therefore, there is a need to identify 
how poor sleep in AS is characterised using objectively assessed total 
sleep time, sleep onset latency, and duration of night waking using 
a clearly defined age range of children with a parent-reported sleep 
problem compared to a control group of TD children.
Few studies have used objective measures to provide detailed 
descriptions of sleep quality in children with AS; one used 
polysomnography (20) and two studies employed actigraphy 
with samples of ≤13 children (19, 21). Actigraphy assessment 
over a minimum of 7 days for 10 children with AS aged 2 to 16 
years, showed means for children’s total sleep time of 406 min 
(SD 55), wake after sleep onset 114 min (SD 33), and sleep onset 
latency of 41 min (SD 23) (19). The authors commented upon 
the extended night waking; however it is important to compare 
actigraphy assessed night waking to that of TD children, in 
order to draw conclusions about the severity of impaired sleep in 
children with AS. A larger actigraphy study of children with AS 
is needed to overcome the limitations of the existing literature.
As sleep in childhood is sensitive to developmental maturation, 
it is also important to assess sleep quality and timing in atypical 
populations compared to an age-matched sample of TD children 
which is lacking in previous studies. The advantage of actigraphy 
assessment of sleep is that it is unobtrusive and sleep timing and 
quality can be monitored across multiple nights, unlike one night 
polysomnography. This would enable night to night variation, 
hereafter referred to as intra-individual variation, in sleep 
quality to be assessed. The assessment of this sleep parameter is 
important, as greater intra-individual variation in sleep offset 
timing is associated with more externalising, inattentive and 
aggressive behaviour in TD pre-school children (22). Aggression 
is frequently reported in individuals with AS (73% prevalence) 
(23), therefore identifying correlates of challenging behaviour in 
this group would elucidate the hypothesis that poor long-term 
sleep quality due to sleep variability does impact upon daytime 
functioning in children with AS.
In addition to the comparison of sleep quality and timing 
of sleep in children with AS who have a parent reported sleep 
disturbance compared to that of age-matched TD children, the 
cross-sectional associations with age in children with AS need 
to be compared against those of TD children. TD children in 
this study provide a benchmark for typical sleep quality for a 
child without AS of the same age. Currently, the profile of sleep 
problems across the developmental trajectory of AS is unclear. 
Retrospective caregiver report from adolescents and adults with 
AS indicate that sleep quality and daytime sleepiness improved 
for 65% of the sample (24). In adulthood, only 56% of a sample of 
53 individuals slept for 8 h or more according to caregiver report 
(25). Other cross-sectional studies using age as a correlate or 
comparing between arbitrary age groups have suggested that sleep 
difficulties persist with age (15, 6). However, these studies did 
not compare age associations with sleep outcomes relative to an 
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age-matched control group. Actigraphy assessments paired with 
sleep diaries would enable sleep timing to be correlated with age.
The aims of this study are to: 1) describe the profile and 
variability of sleep quality and quantity in children with AS 
with a reported sleep problem across a week long assessment, 
2) compare symptoms of sleep disturbance, specifically sleep 
disordered breathing, excessive daytime sleepiness and the role of 
sleep hygiene in children with AS, to those shown by TD children, 
and 3) determine the association between age and total sleep time 
and bedtime for each group and compare across groups.
MATeRiAlS AnD MeThODS
Participants
Twenty-two children with AS with a parent reported sleep 
disturbance were recruited from Angelman UK (Angelman 
syndrome UK support group) and from an existing database of 
families at the Cerebra Centre for Neurodevelopmental Disorders. 
Whilst no statistically significant differences in sleep disturbance 
severity between the genotypes of AS are reported (26, 27, 6) there 
are differences in rates of seizures and motor impairments between 
the AS genotypes (28). Therefore, to cater for known differences 
between the groups, only children with the UBE3A deletion 
subtype of AS were included. Two children did not tolerate 
the Actiwatch for the required four nights and their data were 
excluded from the study. Typically developing (TD) children were 
age-matched to each child with AS and were recruited through 
social media and through family and friends of staff at the Cerebra 
Centre for Neurodevelopmental Disorders. The mean age of 
children with AS was 9.4 years (SD 3.7) (see Table 1). Neither age, 
nor sex differed significantly between the groups. No difference 
in maternal education (X2 = 2.42, p = .658) or family income was 
found between the two groups (X2 = 6.78, p = .342). Medications 
used by children with AS are presented in Table S1.
Procedure
Consent was obtained from parents of participants. The study 
received favourable ethical review from the University of 
TABle 1 | Demographic characteristics.
AS TD T/X2 P value
Age mean (SD) 9.43 (3.72) 9.62 (3.71) T = .155, .879
Males n (%) 8 (40.0) 9 (45.0) X2 = .102, .749
Adaptive Behavior Composite score VABS standard score mean (SD) 43.95 (9.17) – – –
Able to walk unaided n (%)a 7 (37) 20 (100) 18.25 <.001
Ever experienced tonic–clonic seizures 9 (45) – – –
Ever experienced absence seizures 20 (100) – – –
Ever experienced clonic seizures 4 (20) – – –
Ever experienced myoclonic seizures 7 (35) – – –
Ever experienced tonic seizures 2 (10) – – –
Ever experienced atonic seizures 9 (45) – – –
Ever experienced focal seizures 6 (30) – – –
Ever experienced unknown classification of seizures (e.g. epileptic spasms) 3 (15) – – –
Medically refractory epilepsyb 3 (20) – – –
Using medication to aid sleep n (%)c 13 (65.0) – – –
Medication helpful to aid sleepd 10 (76.9) – – –
Maternal educatione Fewer than 5 GCSE’s or O Level’s (grades A–C), NVQ 1 or, 
BTEC First Diploma
2 (10.0) 0 X2 = 2.42 .658
5 or more GCSE’s or O Level’s (grades A–C), NVQ 2, or 
equivalent
2 (10.0) 2 (10.5)
3 or more “A” Levels, NVQ 3, BTEC National, or equivalent 1 (5.0) 1 (5.3)
Polytechnic/university degree, NVQ 4, or equivalent 11 (55.0) 10 (52.6)
Masters/doctoral degree, NVQ 5, or equivalent 4 (20.0) 6 (31.6)
Family incomef Less than £15,000 2 (10.5) 0 6.78 .342
£15,001 to £25,000 2 (10.5) 4 (21.1)
£25,001–£35,000 2 (10.5) 1(5.3)
£35,001–£45,000 4 (21.1) 2 (10.5)
£45,001–£55,000 2 (10.5) 6 (31.6)
£55,001–£65,000 3 (15.8) 1 (5.3)
£65,001 or more 4 (21.1) 5 (26.3)
aOne missing response AS group.
bDefined as defined as inadequate seizure control despite appropriate medical therapy with at least 2 Anti-epilepsy drugs in maximally tolerated doses for 18 months–2 
years, or adequate seizure control with unacceptable drug-related side effects (29) 5 missing responses.
cOne parent indicated that clobazam administered in the evening was helpful to aid sleep. Included this response in using medication to aid sleep. Clobazam was 
administered to three other children in the absence of other medication to aid sleep. As no comment of its efficacy for sleep was reported, these three children were 
excluded from the total.
dOne missing response AS group.
eOne missing response TD group.
fOne missing response AS group, 1 missing response TD group.
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Birmingham. Families were instructed that their child should 
wear an actigraph for seven nights of continuous wear where 
possible. For children with AS a researcher visited the family to 
set up video equipment to record night-time sleep behaviours 
(see 30) and instruct on sleep diary completion and operation of 
the event marker on the actigraph. A comparable training video 
was sent to parents of children in the TD group. Parents completed 
a questionnaire pack and this was returned by post or the pack 
was collected in person by the researcher. The Vineland Adaptive 
Behavior Scales-2 (31) was completed either over the phone or 
in person with the family of children with AS. The measures and 
recruitment of TD children in this study replicate those used in 
study of sleep in children with Smith–Magenis syndrome (32).
Measures
A questionnaire was completed by parents to collect information 
about children’s medication use, epilepsy, maternal education 
and family income. Adaptive ability in the AS group was assessed 
using the Vineland Adaptive Behavior Scales-2 Interview. A 
standardised behaviour composite score for the sample was 
reported. No measure of ability was used in the TD group; 
chronological age was assumed to be commensurate with 
developmental age as no statements of additional learning needs 
were indicated.
Symptoms of Sleep Disturbance and Sleep  
Hygiene Questionnaires
Severe sleep disturbance was assessed using the Modified 
Simonds and Parraga sleep questionnaire (33, 34) which has been 
validated for use with individuals aged 2 to 16 with an autism 
spectrum disorder (34). The presence of severe night waking, 
settling problems and early morning wakings were derived from 
this questionnaire based on the frequency (many times a week 
or daily) and intensity of the problems (e.g. night waking—takes 
over a few minutes to fall back to sleep; settling—takes over an 
hour to fall asleep).
The sleep-related breathing disorders screening questionnaire 
is a 22-item informant report measure from the Pediatric Sleep 
Questionnaire used to assess risk for sleep-related breathing 
disorders, which includes children with obstructive sleep apnoea 
and upper airway resistance syndrome (35). The 22 items relate 
to sleepiness, behaviour, snoring, and breathing subscales and 
sleep-related breathing disorder subscale. Items from the snoring 
subscale only were reported as other subscales require the child 
to be able to communicate their internal state.
Excessive daytime sleepiness was assessed using the 
modified Epworth Sleepiness Scale (MESS; 35). Parents/carers 
rate the likelihood of their child falling asleep in eight different 
situations (0 to 3), with higher scores indicating a greater 
likelihood. The questionnaire is based on the Epworth Sleepiness 
Scale (ESS) for adults. The ESS has good reliability and validity 
(36). The MESS has been used previously with children with 
intellectual disabilities and neurodevelopmental disorders (37). 
As the majority of children with AS are nonverbal, the question 
referring to ‘sitting and talking to someone’ was modified by 
the authors to include ‘sitting and talking to or interacting with 
someone.’ Seven out of the eight questions used in the MESS in 
the present study are similar to those used in a validation study 
of the ESS for Children and Adolescents (38) with individuals 
aged 12–18 years, which showed strong test-retest reliability 
and high internal reliability (39). In the present study a cut off 
score of >10 was used to identify children at risk of excessive 
daytime sleepiness.
Sleep hygiene was assessed using the Family Inventory of 
Sleep Habits (FISH; 40) developed from a sample of children 
with autism spectrum disorder. Items are scored on a five-point 
Likert scale, with higher scores indicating better sleep habits. 
The test-retest reliability of the measure with children with 
autism spectrum disorder is .83, and in the TD population is 
.59. The FISH also has good external validity with measures of 
childhood sleep (40).
Actigraphy
Sleep quality was assessed using the Actiwatch 2, manufactured 
by Philips Respironics. This accelerometer’s sampling rate 
is 32 Hz and 30 s epochs were used. Sleep onset and offset 
were defined as the clock times at the start of the first of 10 
min scored as sleep (after lights out time) and the end of the 
last 10 min scored as sleep respectively. Wake After Sleep 
Onset (WASO) was detected according to the device’s medium 
sensitivity (40 counts per epoch). All other parameters were 
calculated according to default Actiware version 6.0.7’s settings, 
as these settings were found to have the greatest concordance 
with polysmonography (41). Compared to polysomnography, 
these settings have high sensitivity to detect sleep (.94) and 
specificity to detect waking (.69) in school-aged children (42)1. 
Parents were asked to press an event marker button at the child’s 
bedtime. Fifteen children with AS wore the Actiwatch on their 
ankle and five wore it on their wrist. Alternative actigraphy 
placement; a pocket in a cloth vest, has been used in another 
actigraphy study of children with AS (21). All TD children wore 
the Actiwatch on their wrist.
As an adjunct to actigraphy data, parents completed a paper 
sleep diary on behalf of their child to include bedtime (time child 
got into bed), time lights turned off, whether the event marker 
used to indicate bedtime and wake time was pressed at the 
correct time in the evening and morning, estimated time taken 
to fall asleep, wake up time in the morning and time got out of 
bed. Other important data for actigraphy data cleaning were 
collected, to include the timings and nature of any sedentary 
periods of activity after 6 pm, timings of any daytime naps, and 
the timings of periods when the Actiwatch was removed.
Data were cleaned to ensure that artefacts were removed 
and that the start of the intentional rest interval- bedtime was 
identified using a combination of the event marker, sleep diary, 
and the automatically calculated rest interval. This avoided relying 
solely on the software automatically calculated sleep intervals, 
which have poorer concordance with polysomnography (43, 
44). Parental reporting of early morning final wake time may be 
inaccurate; therefore, sleep offset used the end of the autoscored 
rest interval. Intervals were extended to capture the entire sleep 
1Meltzer et al. (42) used 1 min epochs in comparison with polysomnography.
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period if an additional 20 min after the end of the autoscored rest 
period but before the sleep diary indicated wake up time were 
coded as sleep by the software. Inter-rater reliability for 20% of 
the lights out time data in the AS group was excellent (45): intra-
class coefficient: 97 (CI: 94–99).
Analysis
Analyses were conducted using SPSS version 25. As some data 
were non-normally distributed, Mann–Whitney U and Wilcoxon 
Signed Ranks tests were used to compare actigraphy and 
questionnaire data between the AS and TD groups. Chi-squared 
analyses were used to compare categorical outcomes between 
groups. Linear regressions were used to explore the association 
between age and total sleep time and lights out time in both 
groups. To assess the degree of inter-individual variability in sleep, 
the SD of the total sleep time/wake after sleep onset of the group 
was divided by the group mean of the sleep parameter. Intra-
individual variability was calculated by dividing the child’s SD in 
total sleep time/wake after sleep onset from the assessment period 
by the mean of the child’s sleep parameter from the assessment 
period. Effect size was calculated using Cohen R = Z÷√N.
ReSUlTS
Describing Sleep Quality and Quantity
The results shown in Table 2 demonstrate that children 
with AS had significantly earlier lights out times and poorer 
sleep efficiency than TD children. Differences in WASO also 
demonstrated a trend towards greater WASO in the AS group 
compared to the TD group, but the difference between the 
two groups was not statistically significant. No difference 
in sleep quality actigraphy parameters were found between 
children with AS who did or did not take sleep medication 
(see Table S2). When comparing the difference in actigraphy 
parameters between children in the AS group who did not 
receive melatonin (n = 9) and the TD group, there were no 
significant differences on any of the actigraphy parameters (p > 
.05), except earlier average lights out time for the AS group 
(AS group median 20:01, interquartile range 19:25–20:15, U 
= 35.0, p = .008). The same pattern of differences was found 
between children with AS who did receive melatonin (n = 11) 
and children in the TD group (average lights out time AS group 
median 20:04, interquartile range 19:32–20:33, U = 55.5, p = 
.023). No difference in the ratio of weekday versus weekend 
nights was found between the two groups. Furthermore, no 
difference between the average of total sleep time on weekday 
nights and weekend nights was found for children with AS (Z = 
-.859, p = .391) and TD children (Z = -.224, p = .823). Seven 
children with AS (age range: 4.0–13.21 years) had a nap on at 
least one of the days during the assessment period compared 
with three TD children (age range: 5.63–15.75 years). In the AS 
group, individual nap periods ranged from 5 to 240 min. In the 
TD group, individual nap periods ranged from 20 to 100 min.
According to the minimum recommended sleep time 
guidelines (46) seven children with AS and one TD child met the 
recommendations for their age group (X2 = 5.63, 1, p = .018). See 
Table 3 for distributions by age group.
TABle 2 | Grand median and interquartile ranges of actigraphy sleep and daily activity parameters across the assessment period and average duration of daytime naps 
in children with AS and TD children.
AS TD Between-group comparisons
Mann–Whitney U/X2 P Cohen’s R
Nights of actigraphy 7.0 7.0 169.5 .386 .14
Median (IQR) (6.0–8.0) (6.0–7.0)
Ratio weekday/weekend nights .27 .29 155.5 .210 .20
Median (IQR) (.25–.29) (.25–.32)
Lights out time h:min 20:02 20:52 90.50 .003* .47
Median (IQR) (19:30–20:19) (20:25–21:37)
Sleep offset h:min 7:03 7:01 173.50 .473 .11
Median (IQR) (5:58–7:41) (6:29–7:23)
Sleep onset latency min 19.32 15.42 197.50 .946 .01
Median (IQR) (7.12–35.72) (10.45–27.78)
Wake After Sleep Onset min 76.39 56.67 129.0 .055 .30
Median (IQR) (42.44–122.65) (45.52–61.78)
Sleep efficiency (%) 77.86 83.81 124.0 .040* .33
Median (IQR) (71.95–85.69) (81.67–85.67)
Total sleep time min 480.0 497.5 183.5 .655 .07
Median (IQR) (459.83–548.0) (479.5–525.88)
Total sleep time weeknight mins 472.10 500.69 177.0 .534 .08
Median (IQR) (446.34–538.06) (475.90–528.43)
Total sleep time weekend min 491.0 497.25 180.5 .598 .10
Median (IQR) (459.56–572.56) (479.94–542.13)
Average duration of diurnal nap across assessment 
period for children who napped min Mean (SD)
31.08 (44.73) 7.86 (5.58) – – –
Average timing of diurnal nap h:min Mean (SD) 15:59 (2:08) 16:18 (4:06) – – –
*p < .05. Average duration of diurnal nap = total nap duration across assessment period according to sleep diary divided by number of nights of actigraphy data
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inter and intra-individual Variability in Total 
Sleep Time and night Waking
Children with AS had greater variation in night to night (intra-
individual variation) total sleep time and wake after sleep onset 
compared to TD children. Children with AS also had greater 
variation between individuals (inter-individual variation) in total 
sleep time and wake after sleep onset compared to TD children 
(see Table 4).
Sleep hygiene, Symptoms of Sleep 
Disordered Breathing, and excessive 
Daytime Sleepiness
The proportion of children with excessive daytime sleepiness 
did not differ between the two groups AS (n = 2 10.5%) and 
TD (0%), X2 = 2.22, p = .136. Children with AS did not have 
lower scores on the FISH measure of sleep hygiene compared 
to TD children. Children with AS were more likely to snore 
more than half of the time compared to TD children, but no 
other differences in sleep disordered breathing symptoms were 
observed (see Table 5).
Associations Between Age and Total Sleep 
Time and lights Out Time for Children 
With Angelman Syndrome and Typically 
Developing Children
The lights out time for children with AS did not significantly vary 
with age [R2 = .15, F (1, 18) = 3.21, p = .09, β.39] compared to the 
association with later bedtimes for TD children with increasing 
age [R2 = .61, F (1, 18), 28.43 p < .001, β.78] (see Figure 1A). 
Total sleep in children with AS also did not significantly decrease 
with age [R2 < .01, F (1, 18) = .07, p = .799, β -.06] unlike the 
association observed in the TD group [R2 = .59, F (1, 18) = 
25.57, p < .001, β -.77] (see Figure 1B). When the regressions 
were repeated separately for weekend averages (see Figure 1C) 
and weeknight averages (see Figure 1D), a decrease in total sleep 
time only associated with increasing age in on weeknights in the 
TD group [R2 = .63, F (1, 18) = 30.16, p < .001, β.79].
DiSCUSSiOn
This is the largest actigraphy study of children with AS to date 
and the first to report wide inter and intra-individual variability 
in total sleep time and night waking in children with AS. As 
anticipated given the sample of children with AS with a parent 
reported sleep problem, 81% of children with AS had severe 
night waking problems according to a validated questionnaire. 
The data show that children with AS with parent-reported sleep 
problems had significantly earlier lights out times and poorer 
sleep efficiency than TD children and that a minority of children 
with AS napped during the day. No significant differences in 
total sleep time, wake after sleep onset and sleep offset time were 
found compared to TD children. Children with AS did not have 
an excess of daytime sleepiness compared to TD children, but 
were more likely to snore more than half the time (24 versus 
0% of children) and, significantly, no difference in sleep hygiene 
practices were found between the two groups. Cross-sectional 
associations between lights out time, total sleep time and age 
indicated that increasing age is not associated with later bedtimes 
and decreased total sleep time in the AS group, unlike the 
relationship found for the TD group. The use of an age-matched 
TD contrast group in the first case–controlled actigraphy study of 
TABle 3 | Proportions of children with AS and TD children meeting 
recommended minimum total sleep.
AS TD
n (%) n (%)
Children aged 4–5 years average TST ≥ 10 h 2 (40) 0
Children aged 6–12 years average TST ≥ 9 h 1 (10) 1 (9)
Children aged 13–15 years average TST ≥ 8 h 4 (80) 0
TABle 4 | Coefficient of variance statistics for total sleep time and wake after 
sleep onset between children and within an individual child’s assessment period 
in children with AS and TD children.
AS TD
Inter-individual coefficient of variance TST (%) 12 8
Inter-individual coefficient of variance WASO (%) 60 24
Intra-individual coefficient of variance TST (%) 15 10
Intra-individual coefficient of variance WASO (%) 53 24
TABle 5 | Scores on questionnaire measures of sleep hygiene, likelihood of dozing during daytime activities, sleep-related breathing disorders, and sleep disturbance 
for TD and AS groups.
AS n AS TD n TD U statistic/X2 P value
Median sleep hygiene score on FISH† (IQR) 18 50.50 (46.75–56.50) 19 51.0 (47.0–54.0) 157.0 .670
Median pediatric Epworth sleepiness scale score † (IQR) 19 1.0 (0–6.0) 20 2.0 (1.0–3.0) 175.0 .669
Number (%) of children with severe settling problems 18 2 (11.1) 20 0 2.35 .126
Number (%) of children with severe night waking problems 16 13 (81.3) 20 1 (5.0) 21.75 < .001
Number (%) of children with severe early morning waking problems 19 4 (21.1) 20 1 (5.0) 2.25 .134
Always snores 16 0 (0)a 20 0 (0) – –
Snores more than half the time 17 4 (23.5) 19 0 (0) 5.03 .025
Snores loudly 16 1 (6.7)a 20 0 (0) 1.37 .241
Has heavy or loud breathing 17 7 (43.8)a 20 3 (15.0) 3.66 .056
Has trouble breathing, or struggles to breathe 16 1 (6.7)a 20 0 (100) 1.37 .241
aOne parent reported “don’t know”.
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children with AS has enabled the benchmarking of impairment 
in sleep quality and differences in sleep timing.
These findings contrast from previous studies which indicate 
that individuals with AS have reduced total sleep time (see 19, 47). 
Our findings show that more children with AS sleep on average for 
the minimum recommended time than TD children. Given the 
inclusion criterion of children with AS with a parent-reported sleep 
disturbance, should the reported total sleep time be shorter in the 
wider AS population, we would have expected to have replicated this 
finding. It is possible that the TD group over-represented children 
with poor sleep quality, as in another study the average actigraphy 
assessed total sleep time in a large sample of children aged 9–11 
years in the United Kingdom (48) met the minimum criteria advised 
by the American Academy of Sleep Medicine for this age group (45). 
The lack of relationship between age and bedtime in the AS group 
in contrast to the TD group is relevant to this finding. It has been 
suggested that it is environmental factors, as opposed to biological 
mechanisms, that may be responsible for the reduction in total sleep 
time with age in TD children (49, 50), as the decrease in total sleep 
time with age was only found on school days in one meta-analysis 
(47) and in the present study. This finding suggests that it may not be 
the case that the required sleep duration for TD children decreases, 
but that environmental constraints such as additional activities in 
the evening result in later bedtimes, as observed in Figure 1A, which 
reduces the time in bed and subsequent sleep period. Children with 
AS may not have the same demands on their time in the evening for 
extra-curricular and social activities, as their adaptive ability does 
not increase in line with their TD peers. Given the lack of difference 
in sleep onset latency between the groups, it would suggest that 
bedtimes in children with AS are aligned with their circadian 
phase. However, further research using melatonin assays to assess 
the timing of endogenous melatonin secretion onset is needed to 
explore whether children with AS have a circadian phase shift, as 
risk for circadian rhythm disorders has been identified in a small 
sample of individuals with AS (8). Further research is also needed 
both within TD and AS populations to investigate the hypothesised 
biological mechanisms of phase shift with age.
Despite the lack of difference between children with AS 
and TD children in total sleep time and wake after sleep onset, 
it is important to note that all parents of children with AS who 
participated in this study considered their child to have a sleep 
problem, and 81% had severe night waking problems according 
to a questionnaire definition. It is possible that heightened levels 
of night waking reported by parents in the AS group are due, in 
part, to greater self-soothing skills in the TD group, such that the 
TD children wake their parents less frequently and therefore night 
waking is under reported by parents of TD children. Additionally, 
it is possible that as children with AS are likely to have limited self-
soothing skills due to their low adaptive ability, night wakings are 
extended as parents need to enter the child’s room which may be 
more stimulating and hinder the child’s ability to fall back to sleep 
quickly. Night waking duration varied substantially both between 
children with AS and from one night to another. This variability 
warrants further exploration. It is possible that the variance in 
night waking may be associated with nocturnal seizure frequency, 
however we do not have nightly reports on seizure frequency 
and duration to test this hypothesis. This has implications for 
FigURe 1 | (A) Relationship between lights out time and age in children 
with AS and TD children. (B) Relationship between total sleep time and 
age in children with AS and TD children. (C) Relationship between total 
sleep time at the weekend and age in children with AS and TD children. (D) 
Relationship between total sleep time on weeknights and age in children 
with AS and TD children.
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assessment, namely that the severity of night waking using the 
average from children in one study cannot be generalised across 
children with AS. It is more important to assess sleep quality in 
children individually, and to evaluate night waking duration on 
multiple nights and consider the pattern of variation in sleep 
quality for each child. The detrimental impact of caring for a 
child with disturbed sleep cannot be underestimated, as parents 
of children with AS cite the impact of the impact of their child’s 
sleep problems on their own ability to function as a concern (51).
According to parental report of sleep disordered breathing 
symptoms, children with AS were more likely to snore more than 
half the time compared to TD children, although no child always 
snored. Preliminary evidence from a sleep questionnaire suggests 
that children with AS may be at risk of sleep disordered breathing 
compared to TD children (12), and habitual snoring reported for 
24% of the AS sample is higher than the 9% reported for community 
samples using the same definition (52). However, these data were 
drawn from a small sample (n = 17), so caution is needed to 
generalise this finding to the wider AS population. However, given 
these rates of reported habitual snoring objective cardiorespiratory 
sleep studies should be performed with low threshold of clinical 
suspicion in this vulnerable group. Children with AS were not more 
likely to experience excessive daytime sleepiness according to the 
MESS. This finding does support previous literature demonstrating 
low prevalence of daytime sleepiness among individuals with AS 
(6, 13–15). The lack of excessive daytime sleepiness in both groups 
could reflect the lack of difference in average total sleep time between 
the groups. No differences in sleep hygiene practices were found 
between the two groups, therefore poorer sleep efficiency cannot be 
attributed to a distracting or uncomfortable bedroom environment 
or routines, particularly with regard to providing children with 
attention during the night. This is encouraging as children with 
AS are effective in obtaining social attention from adults (53). This 
suggests that whilst sleep hygiene needs to be examined on a case by 
case basis for each family, interventions for sleep in children with AS 
may not need to focus particularly on parent-child interactions at 
night, despite the strong motivation for social interaction observed 
in children with AS. However, it should be acknowledged that 
parents of children with AS may have had a different interpretation 
of brief interactions. Therefore, the role of parent-child interactions 
during night wakings needs to be explored using video footage and 
objective coding of interaction length and social approaches.
limitations
There are some limitations to the design of this study, 
predominantly the wrist placement of the Actiwatch for TD 
children and ankle placement for the majority of children with 
AS. A review suggests that whilst further research is needed, data 
obtained via ankle placement do not differ to those obtained 
via wrist placement (54). Due to children with AS’s limited 
receptive language, it was difficult to encourage children to wear 
the Actiwatch on their wrist and explain the value of wearing the 
watch. The Actiwatch was more often tolerated on the ankle when 
it was out of sight. On balance, it was felt that the statistical power 
obtained by including a greater number of children with a rare 
genetic syndrome in the study outweighed the risk of extraneous 
variance between the groups due to differential placement of 
the Actiwatch, however, it is possible that ankle placement may 
have underestimated wake after sleep onset if children had more 
limited leg movements compared to arm movements during the 
night. Whilst still the largest actigraphy sample of children with 
AS to date, the small sample size does limit the generalisation 
of these findings to other children with the deletion subtype 
of AS. Whilst polysomnography is often considered the ‘gold 
standard’ method of objectively assessing sleep, children with 
AS may struggle to tolerate wearing the equipment. Additionally, 
polysomnography can fail to capture habitual sleep/wake patterns 
in an ecologically valid sleep environment. Therefore, actigraphy 
was used to assess sleep in this population. Of note is that whilst 
we did not find differences in actigraphy parameters between 
children who were and were not administered medication to aid 
sleep, the cause of sleep disturbance in these two subgroups may 
be different.
Whilst it is informative to compare the cross-sectional 
relationships between sleep quantity and timing and age between 
children with AS and TD children, these data do not account 
for individual differences in children’s trajectories over time. 
Given the wide inter and intra-individual variation in total 
sleep time, it is important to approach these data with caution. 
A longitudinal study is required to confirm the difference in 
sleep quantity and timing with age in children with AS when 
interpersonal variation is accounted for. A longitudinal study 
could also identify the age at which sleep quality in children 
with AS diverges from the trajectory seen in TD children. We 
were unable to measure daytime melatonin in children with AS 
as the actigraphy and sleep diary data collection were facilitated 
by parents at home to maximise participation and also to ensure 
that data were ecologically valid. This does limit the discussion of 
the mechanisms that underpin interpersonal variation in sleep 
duration and quality among children with AS, as melatonin 
profiles in children with AS are disturbed (9). The measurement 
of endogenous melatonin should be a priority for future studies.
Conclusions
This study generated the largest objective dataset of sleep quality 
parameters in children with AS. Sleep quality was characterised 
by a high degree of variability, both among children with AS 
with parent-reported sleep disturbance, and between nights for 
each individual child. This variability needs to inform further 
assessments of and interventions for sleep in children with AS, 
as averages of total sleep, even across a seven night period do 
not capture the difficulties with night waking highlighted by 
parental questionnaire report. No change in total sleep time with 
age unlike that found in TD children on weekday nights was 
hypothesised to be accounted for by the lack of environmental 
and social constraints on children with AS.
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